arBtrage CAPITALIZING MARKETS checking… Sign in

Annovis Bio, Inc.

ANVS Health Care Biotechnology: Pharmaceutical Preparations
$1.89
▼ -5.0% Today
as of Jun 7, 07:09 ET
Last 30 days +2.16% Apr 28 → Jun 05
$1.77 $1.94 $2.11 $2.28 $2.45 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.94
High
$1.96
Low
$1.85
Volume
$1M
Avg Vol
$926,206
Mkt Cap
$66M
P/E (TTM)
Beta
52w High
$5.50
52w Low
$1.54
Div Yield
Shares Out
$29M

Overview

52-week range
$1.54
$5.50
9% of range
Avg surprise (last 1)
+31.9%
Avg reaction (last 2)
+3.2%
50% positive
Latest IV / EM
113%
EM ±10.6% · $2 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.63$-1.30$-0.97$-0.65$-0.32 Actual $-1.07Actual $-1.63Actual $-0.72Actual $-0.44Actual $-0.97Actual $-0.32Est $-0.47Actual $-0.32Actual $-0.37Actual $-0.63 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-18M$-15M$-11M$-8M$-5M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.63 -96.9% -3.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.37 financials
Mon Jun 30, 2025Jun 2025 $-0.32 financials
Tue May 13, 2025Mar/2025 $-0.32 $-0.47 +31.9% +9.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.97 financials
Sun Jun 30, 2024Jun 2024 $-0.44 financials
Sun Mar 31, 2024Mar 2024 $-0.72 financials
Sat Sep 30, 2023Sep 2023 $-1.63 financials
Fri Jun 30, 2023Jun 2023 $-1.07 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-18M$-7M$-6M$-6M$-4M$-8M
Net income$-18M$-7M$-6M$-6M$-13M$-5M
EPS (diluted)$-0.63$-0.37$-0.32$-0.32$-0.97$-0.44

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$14M$20M$15M$17M$22M$11M$13M$4M
Inventory
Total current assets
Total assets$16M$21M$17M$21M$27M$14M$14M$5M
Long-term debt
Total liabilities$13M$4M$4M$3M$3M$5M$7M$7M
Total equity$3M$17M$13M$18M$24M$9M$7M$-2M

Implied volatility — last 90 days

108%110%113%115%118% Jun 07 — IV 113% · EM ±10.6%

Sector peers